Cannabis Science Inc news

   Watch this stock
Showing stories 11 - 20 of about 82   

Articles published

CBIS 0.0149 -0.0013 (-8.02%)
price chart
Cannabis Science Inc (OTCMKTS:CBIS) Back Into Focus
Cannabis Science Inc (OTCMKTS:CBIS) reported a Historic Collaborative Drug Development agreement with IGXBio and its GenePro�, that recently obtained FDA IND approval to start with human trials.
Cannabis Science Inc (OTCMKTS:CBIS) Is Back Where it Began
Cannabis Science Inc (OTCMKTS:CBIS) is sitting just under $0.03 on continued excellent volume and strong support. CBIS takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses ...
Cannabis Science Inc (OTCMKTS:CBIS) Stock in Focus
Cannabis Science Inc (OTCMKTS:CBIS) was one of the original pot stocks that lit up the bb's and made spectacular gains for investors.
Cannabis Science, Inc. indica un destacado inter�s de los clientes
Tras presentar sus productos en un destacado evento mundial de cannabis, Cannabis Science, Inc. indica un destacado inter�s de los clientes.
Cannabis Science, Inc. Initiates the Scientific Validation of the Biological ...
Cannabis Science, Inc. (OTC PINK: CBIS), and a key member of its scientific advisory board, Harold C. Smith, Ph.D., Professor in Biochemistry, Biophysics, and Oncology and the Center for RNA Biology at the University of Rochester, School of Dentistry ...
Cannabis Science, Inc. Initiates the Scientific Validation of the Biological ...  SYS-CON Media (press release)
Enter your email address:  Stockhouse
Cannabis Science Inc (OTCMKTS:CBIS) Acquires Equi-Pharm To Enter In PET Care ...
Cannabis Science Inc (OTCMKTS:CBIS) has entered into PET Care industry by acquiring one of the leading PET Care product manufacturers and distributors named Equi-Pharm.
Cannabis Science Inc (OTCMKTS:CBIS) Drifting Away
Cannabis Science Inc (OTCMKTS:CBIS) continues to trade lower in recent days on decelerating volume. The stock has been at the forefront of the pot stock revolution that has swept up small caps and produced most of the biggest winners in recent penny ...
Cannabis Science President & CEO, Raymond C. Dabney is named Vice Chair ...  PR Newswire (press release)
Cannabis Science Inc (OTCMKTS:CBIS) Brings CS-TATI-1 To The US FDA
Cannabis Science Inc (OTCMKTS:CBIS) a company into the development of cannabis-based consulting, reported a major Collaborative Drug Development agreement with IGXBio and its GenePro�, which is a DNA-based immunotherapeutic.
Cannabis Science, Inc. (CBIS) to Release 8 Initial Cannabis-Based Products ...
The products are currently ready for pre-clinical studies, self-medicating patient ailment usage, marketing release, sales and distribution.
Related articles »  
After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis ...
COLORADO SPRINGS, Colo., March 26, 2015 /PRNewswire/ -- Choosing to present its products to the world at this year's Spannabis Fair, held March 20-22 in Barcelona, Spain, Cannabis Science, Inc. (OTCQB: CBIS) immediately began meeting with ...
Cohen Grassroots Research, Inc. To Begin Analytical Coverage On Cannabis ...  Journal Transcript